| 1 |
Post Approval changes for clinical trials (Form CT-06) for CGTP through SUGAM Online Portal |
2025-Oct-29 |
|
585 KB |
| 2 |
Withdrawal of Covid-19 indication of Baricitinib Tablets 2mg & 4mg |
2025-Oct-23 |
|
286 KB |
| 3 |
Digital Monitoring System on the ONDLS portal for monitoring the supply chain of high-risk solvents |
2025-Oct-22 |
|
577 KB |
| 4 |
The list of standards published under Medical Equipment and Hospital Planning (MHD) of BIS as forwarded in 2025 |
2025-Oct-22 |
|
367 KB |
| 5 |
Draft guidance document on conduct of Medical Device Software under MDR 2017 |
2025-Oct-21 |
|
1945 KB |
| 6 |
Notice for inviting comment to ensure a level playing field in new drug approval in India |
2025-Oct-08 |
|
597 KB |
| 7 |
Strict compliance with the Drugs Rules 1945 for testing of raw materials and finished formulations |
2025-Oct-07 |
|
418 KB |
| 8 |
Clarification for grant of permission for combipack product of lyophilised dry powder for injection /I.V infusion and diluents for reconstitution such as sterile water for injection / sodium Chloride Injection |
2025-Sep-29 |
|
301 KB |
| 9 |
ICMR-CDSCO Standard Performance Evaluation Protocols |
2025-Sep-17 |
|
7383 KB |
| 10 |
Clarification for regulatory pathway for Cocrystals |
2025-Sep-15 |
|
546 KB |
